A novel TB vaccine; towards a strategy based on our understanding of BCG failure
- 2 October 2002
- Vol. 21 (1-2) , 7-14
- https://doi.org/10.1016/s0264-410x(02)00447-4
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Induction of Cell-Mediated Immunity againstMycobacterium tuberculosisUsing DNA Vaccines Encoding Cytotoxic and Helper T-Cell Epitopes of the 38-Kilodalton ProteinInfection and Immunity, 2001
- Immunology of TuberculosisAnnual Review of Immunology, 2001
- THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and GlycolipidsAnnual Review of Immunology, 1999
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Differential Effects of Cytolytic T Cell Subsets on Intracellular InfectionScience, 1997
- The CD1-restricted T-cell response to mycobacteriaResearch in Immunology, 1996
- Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literatureJAMA, 1994
- Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-AnalysisInternational Journal of Epidemiology, 1993
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- BCG: who were Calmette and Guerin?Thorax, 1983